Main Conference Topics/Sessions

Session 1: Functional Food Definition and the Status of Functional Foods in Japan, USA and other Countries
  • The regulations, policy, and labeling of functional foods in Japan
  • Weaknesses and strong points of FOSHU/Food for Special Health Usage
  • What is the status of Functional Foods in the USA? Expert opinions from NIH, USDA, and FDA
  • How the new definition of Functional Foods can help to improve the status of functional foods word wide
Session 2: Functional foods, Bioactive Compounds and Nutrition for Obesity
  • Epidemiology of obesity
  • The modern mechanisms of obesity; energy metabolism and obesity; neurobiological mechanisms of obesity; microbiological mechanisms of obesity; pathophysiologic mechanisms of obesity
  • Biomarkers of obesity
  • The effects of functional food and bioactive compounds on biomarkers of obesity
  • Nutrition, Functional, and Medical foods for obesity
Session 3: Functional foods, Bioactive Compounds and Nutrition for Patients with Prediabetes and Diabetes (Session Chairs: Debasis Bagchi, PhD, Professor, University of Houston College of Pharmacy, Houston, TX, USA, and Dr. Harry Preuss, PhD, Professor, Depa rtment of Biochemistry, Georgetown University Medical Center, Washington, D.C, USA)
  • Epidemiology of diabetes
  • The modern mechanisms of diabetes
  • Biomarkers of diabetes
  • The effects of functional food and bioactive compounds on biomarkers of diabetes
  • Nutrition, Functional, and Medical foods for diabetes
 
Session 4: Functional foods, Bioactive Compounds and Nutrition for Neurological Diseases
 
  • Epidemiology of mental and neurological diseases
  • Mechanisms of neurological diseases
  • Biomarkers of different mental and neurological diseases
  • The effects of functional food and bioactive compounds on biomarkers of neurological diseases
  • Functional foods for mental and neurological diseases
  • Nutrition, Functional and Medical foods for neurological diseases
 
Session 5: Functional foods, Bioactive Compounds and Nutrition for Cardiovascular Diseases (CVD)
 
  • Epidemiology of CVD
  • Biomarkers of different cardiovascular diseases
  • The effects of functional food and bioactive compounds on biomarkers of cardiovascular diseases
  • Nutrition, Functional, and Medical foods for CVD
 
Session 6: Functional foods, Bioactive Compounds and Nutrition for Cancer (Session Chair: Dr. Jin-Rong Zhou, Co-chairman: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA)
 
  • Epidemiology of Cancer
  • Biomarkers of different types of cancer
  • The effects of functional food and bioactive compounds on biomarkers of different types of cancer
  • Nutrition, Functional, and Medical Foods for the Cancer
 
Session 7: Functional Foods and Healthy Aging (Session Chair: Dr. Gabriela Riscuta, Founder and Scientific Co-chair Cancer and Aging Interest Group, National Cancer Institute (NCI/NIH), Rockville, Maryland)
 
  • Biology of Aging: Understanding the Cellular and Molecular Processes of Age-related Diseases
  • Aging and Chronic Diseases
  • Biomarkers of Aging: a)Physical Function b) Blood-Based Biomarkers c)DNA-Based Markers d) Novel markers
  • Diet, Nutrition and Aging
  • Functional Food Products and Healthy Aging
  • Understanding and Extending the Lifespan: Caloric Restriction, Intermittent Fasting, Time-restricted Feeding
 
Session 8: Functional Foods with Bioactive Compound(s): Prevention and Management of Non-communicable Diseases (Session Chairs: Dr.Amrendra Ajay, Harvard Medical School, Boston, MA, and Dr. Machelle Seibel, Harvard Medical School, Boston, MA)
 
  • Functional foods and other non-communicable diseases
  • Bioactive compounds and other non-communicable diseases
  • The effects of medical food on biomarkers of non-communicable diseases
 
Session 9: Safety of the Bioactive Compounds and Functional Foods (Session Chair: Kanakaraju Kaliannan, MD, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA)
 
  • Food-Drug Interactions
  • Safety of bioactive compounds at efficacious levels
  • Safety of functional foods at efficacious levels
  • Regulatory issues and health claims
 
Session 10: Biomarkers and Functional Food
 
  • Biomarkers and functional foods
  • Biomarkers available for assessing diet-related changes
  • How can biomarkers improve functional food products development process?
  • The importance of Monitoring Biomarkers in Functional food Science
  • FDA’s Biomarker Qualification Program and creation of new functional foods
 
Session 11: Current Research and Development of New Functional and Healthy Food Products (Session Chair: Dr. Danik Martirosyan, Functional Food Center/Functional Food Institute, Dallas, TX, USA)
 
  • Incentives for functional and healthy food research and development
  • Consumer acceptance of healthy and functional food products
  • Functional food composition and dietary intake databases
  • Food vehicles for delivery bioactive compounds
  • Research, development and marketing of new healthy and functional food products
 
Session 12: The Human Microbiome, Diet, Functional Foods, and Health
 
  • The microbiome, health, and disease
  • How diet impacts the microbiome
  • Diet, obesity, and the gut microbiome
  • Impact of microbiome on oral and gastrointestinal health
  • Future market of functional food products for human microbiome
  • Translation of probiotic and prebiotic science into probiotic and prebiotic foods
  • How to build and preserve health capital through food